기관지폐이형성증의 유형 및 중증도에 따른 임상적 특징
Clinical Characteristics of Bronchopulmonary Dysplasia by Type and Severity
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
목적:최근 신생아중환자실에서 생존률이 향상됨에 따라서 기관지폐이형성증의 발생률이 증가하고 있고, 그 중에서도 특히 비전형적 기관지폐이형성증의 발생률이 증가하고 있다. 그러나, 전형적인 기관지폐이형성증 환아와 비전형적 기관지폐이형성증 환아의 비교 연구는 많지 않다. 이에 저자들은 두 군간의 차이점을 알아보고자 본 연구를 시행하였다. 방법:2004년 5월부터 2007년 4월까지 서울대학교병원과 분당 서울대학교병원에서 출생하여 신생아중환자실에 입원한 월경 후 주령 32주 미만인 환아를 대상으로 하였고, 이를 전형적인 군과 비전형적인 군으로 나누었다. 그리고, 기관지 폐이형성증의 발생률을 조사하고, 전형적인 군과 비전형적인 군에서 주산기적 요인과 출생 후 치료를 비교하였다. 결과:총 연구 대상은 260명이었고 이 중 141명(54.2%)이 기관지폐이형성증으로 진단되었다. 이 중 전형적 기관지폐이형성증은 64명, 비전형적 기관지폐이형성증은 77명이었다. 전형적 기관지폐이형성증 환아에서 신생아 호흡곤란 증후군, 동맥관 개존증, 자궁내 성장지연이 더 많이 동반되었고, 1분과 5분 Apgar 점수가 낮았고, 고진동 인공환기기 사용이 더 많았다. 비전형적 기관지폐이형성증 환아에서는 산전 스테로이드 사용이 더 많았고, 조기 양막파수, 임상적 융모양막염과 병리학적 융모양막염의 동반이 더 많았다. 다중 로지스틱 회귀분석을 시행하였을 때 고진동 인공환기기 사용은 전형적 기관지폐이형성증 환아에서 독립변수였고, 산전 스테로이드 사용, 임상적 융모양막염과 병리학적 융모양막염은 비전형적 기관지폐이형성증 환아에서 독립변수였다. 결론:본 연구에서는 산전 요인(산전 스테로이드 사용, 임상적 융모양막염, 병리학적 융모양막염)은 비전형적인 기관지폐이형성증과 유의한 관계를 보였고, 산후 요인(더 흔한 고진동 인공환기기 사용)은 전형적 기관지폐이형성증과 유의한 관계를 보였다. 앞으로, 위와 같은 임상 연구들을 바탕으로 기관지폐이형성증의 예방과 치료에 대한 더 많은 연구가 필요하리라 생각된다.
Abstract
Purpose:The increased survival of preterm infants in the neonatal intensive care unit recently has resulted in an increased frequency of bronchopulmonary dysplasia (BPD), especially with atypical forms. However, there have been few studies compairing classic and atypical BPD. The aim of this study was to investigate the differences between these two types of BPD. Methods:Infants with a gestational age less than 32 weeks born at the Seoul National University Hospital and Bundang Seoul National University Hospital from May 2004 to April 2007 were included. The data were categorized in 2 groups, classic and atypical BPD. We determined the incidence of BPD, and compared perinatal factors and postnatal managements between two groups. Results:Among 260 study subjects, 141 (54.2%) infants had BPD. Classic BPD infants were 64 and atypical BPD infants were 77. Comparison of differences between 2 groups, classic BPD infants were associated with respiratory distress syndrome, patent ductus arteriosus, intrauterine growth restriction, more high-frequency ventilator (HFV) use, low 1 and 5 minute Apgar scores. Atypical BPD infants were associated with antenatal steroid use, maternal premature rupture of membrane and chorioamnionitis (CAM). In multivariate analysis, more HFV use was associated with classic BPD. Antenatal steroid use, clinical CAM and histological CAM were associated with atypical BPD. Conclusion:The results of this study showed that antenatal factors (antenatal steroid use, clinical CAM, histological CAM) were associated with atypical BPD and postnatal factors (HFV used was) were associated with classic BPD. Further studies are needed for prevention and treatment of BPD.
참고문헌 (41)
- Northway WH Jr, "Pulmonary disease following respirator therapy of hyaline membrane disease. Bronchopulmonary dysplasia", N Engl J Med, 276, pp.357~368 (1967)
- Jobe AH, "Bronchopulmonary dysplasia", Am J Respir Crit Care Med, 163, pp.1723~1729 (2001)
- Charafeddine L, "Atypical chronic lung disease patterns in neonates", Pediatrics, 103, pp.759~765 (1999)
- Choi CW, "Clinical characteristics of chronic lung disease without preceding respiratory distress syndrome in preterm infants", Pediatr Int, 47, pp.72~79 (2005)
- Kim BI, "Morphologic change of lung parenchymal tissue in neonatal rat pups under chronic hyperoxia", J Korean Pediatr Soc, 37, pp.1055~1064 (1994)
- Choi CW, "Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: morphometric aspects", Pediatr Res, 65, pp.323~327 (2009)
- Lyon A, "Chronic lung disease of prematurity: The role of intra-uterine infection", Eur J Pediatr, 159, pp.798~802 (2000)
- Speer CP, "Inflammation and bronchopulmonary dysplasia", Semin Neonatol, 8, pp.29~38 (2003)
- Kramer BW, "Antenatal inflammation and lung injury: prenatal origin of neonatal disease", J Perinatol, 28(Suppl 1), pp.21~27 (2008)
- Bose CL, "Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate", Arch Dis Child Fetal Neonatal Ed, 93, pp.455~461 (2008)
- Rojas MA, "Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease", J Pediatr, 126, pp.605~610 (1995)
- Fujimura M, "Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema", Pediatrics, 92, pp.564~569 (1993)
- Watterberg KL, "Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops", Pediatrics, 97, pp.210~215 (1996)
- Yoon BH, "Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia", Am J Obstet Gynecol, 177, pp.825~830 (1997)
- Yoon BH, "A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia", Am J Obstet Gynecol, 181, pp.773~779 (1999)
- Kim BI, "Interleukin-8 and neutrophils in the tracheobronchial aspirate at birth and the risk for the development of chronic lung disease of prematurity", Prenat Neonatal Med, 5, pp.375~382 (2000)
- Lee JA, "Immediate Postnatal Concentrations of Metalloproteinase-8 in the Tracheal Aspirates and the Development of Atypical Chronic Lung Disease of Prematurity", J Korean Soc Neonatol, 10, pp.153~167 (2003)
- Kim BI, "Increase in cord blood soluble E- selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia", J Perinat Med, 32, pp.282~287 (2004)
- Kim DH, "Cord Blood KL-6, a Specific Lung Injury Marker, Correlates with the Subsequent Development and Severity of Atypical BronchopulmonaryDysplasia", Neonatology, 93, pp.223~229 (2008)
- Choi CW, "Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants", Acta Paediatr, 95, pp.38~43 (2006)
- Panickar J, "Atypical chronic lung disease in preterm infants", J Perinat Med, 32, pp.162~167 (2004)
- Skinner J, "Diagnosis of patent ductus arteriosus", Semin Neonatol, 6, pp.49~61 (2001)
- Henry GW, "Noninvasive assessment of cardiac function and pulmonary hypertension in persistent pulmonary hypertension of the newborn", Clin Perinatol, 11, pp.627~640 (1984)
- Walsh MC, "Necrotizing enterocolitis: a practitioner's perspective", Pediatr Rev, 9, pp.219~226 (1988)
- The Committee for the Classification of Retinopathy of Prematurity, "An international classification of retinopathy of prematurity", Pediatrics, 74, pp.127~133 (1984)
- Gibbs RS, "Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term", J Infect Dis, 145, pp.1~8 (1982)
- Salafia CM, "The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies", Obstet Gynecol, 73, pp.383~389 (1989)
- Ballard RA, "Inhaled nitric oxide in preterm infants undergoing mechanical ventilation", N Engl J Med, 355, pp.343~353 (2006)
- Furman L, "Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease", J Pediatr, 128, pp.447~452 (1996)
- Berger TM, "Impact of improved survival of very low- birth-weight infants on incidence and severity of bronchopulmonary dysplasia", Biol Neonate, 86, pp.124~130 (2004)
- Garland JS, "Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome", Arch Pediatr Adolesc Med, 149, pp.617~622 (1995)
- Gonzalez A, "Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less", J Pediatr, 128, pp.470~478 (1996)
- Kraybill EN, "Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams", J Pediatr, 115, pp.115~120 (1989)
- Marshall DD, "Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association", Pediatrics, 104, pp.1345~1350 (1999)
- 최창원, "조산아에서의 신생아 만성폐질환의 분류 및 위험인자:전형적 만성폐질환과 비전형적 만성폐질환의 비교", Korean Journal of Pediatrics, 44(11), pp.1222~1232 (2001), 대한소아과학회
- Kim YD, "Clinical characteristics of premature infants with atypical chronic lung disease", J Korean Soc Neonatol, 9, pp.45~49 (2002)
- Kotecha S, "Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity", J Pediatr, 128, pp.464~469 (1996)
- Matsuda T, "Necrotizing funisitis: clinical significance and association with chronic lung disease in premature infants", Am J Obstet Gynecol, 177, pp.1402~1407 (1997)
- Choi Chang Won, "Decreasing Incidence of Chronic Lung Disease Despite the Gradual Reduction of Postnatal Dexamethasone Use in Very Low Birth Weight Infants", Journal of Korean Medical Science, 19(4), pp.514~518 (2004), 대한의학회
- Grier DG, "Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use", Drugs, 65, pp.15~29 (2005)
- Bancalari E, "Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition", Semin Neonatol, 8, pp.63~71 (2003)
